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Abstract Origins of hyperlipidemia and cholestasis that
occur during pregnancy were investigated by examining
expression of key elements related to plasma and hepatic
cholesterol metabolism during pregnancy, lactation, and
post-lactation in the rat model. Among major findings were:
during pregnancy, the activities of hepatic 3-hydroxy-3-
methylglutaryl coenzyme A reductase, acyl coenzyme A:cho-
lesterol acyltransferase, acyl coenzyme A:diacylglycerol acyl-
transferase, cholesterol 7
 
a
 
-hydroxylase, cholesterol ester
hydrolases, low density lipoprotein receptors, LRP, and
mdr2 were significantly lower or similar to non-pregnant
controls while SR-B1 was elevated. Once lactation began, re-
ductase, cholesterol acyltransferase, 7
 
a
 
-hydroxylase activi-
ties, low density lipoprotein receptors, and mdr2 increased
while SR-B1 decreased. In later stages of lactation most he-
patic elements returned to near control levels. Plasma cho-
lesterol levels were higher than control at birth and during
lactation with increase in LDL-size particles. By 24 h post-
lactation, plasma triglycerides were 3.7-fold higher while
cholesterol remained unchanged. Very large lipoproteins
were present while LDL-size particles were now absent. He-
patic cholesterol acyltransferase had decreased to 27% of
control while diacylglycerol acyltransferase increased 3-fold
and low density lipoprotein receptors doubled. Most ele-
ments were normalized 3 weeks after weaning except for
LRP and low density lipoprotein receptors which were ele-
vated.  These studies provide an integrated picture of ex-
pression of key elements of hepatic and plasma cholesterol
metabolism during pregnancy and lactation and advance un-
derstanding of hyperlipidemia and cholestasis during these
states.—
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Hyperlipidemia of pregnancy in humans was first de-
scribed over 150 years ago (1) and has been studied exten-
sively since (2–7). It occurs in virtually all pregnant
 
women and resolves in most in the first months after deliv-
ery. A positive association of this hyperlipidemia with later
development of cardiovascular disease has been suggested
(8); and a supraphysiologic increase has been proposed as
a marker for development of non-pregnancy-associated
hyperlipidemia in later life (9). A low density lipoprotein
(LDL)
 
 
 
pattern B profile, i.e., one predisposing towards
the development of atherosclerosis (10), has been de-
scribed in pregnant women which tended to revert to-
wards a more favorable LDL pattern A in most individuals
by 4–5 weeks after delivery (11). Cholesterol and lipopro-
tein concentrations tend to normalize in the year after
pregnancy (12, 13). Epidemiological studies of the rela-
tionship(s) between pregnancy and later risk for cardio-
vascular disease have shown mixed results (14 and refer-
ences therein).
An increased propensity for cholesterol gallstone for-
mation in human pregnancy also is well known (15, 16)
and is a predictor for development of cholesterol gall-
stone disease in later life (17). Intrahepatic cholestasis of
pregnancy also is a well-described entity in humans which
generally also resolves after delivery. It was first noted over
100 years ago (18) and described in detail in 1954 (19). It
is associated with higher than normal serum lipid levels
during pregnancy (20, 21), suggesting a link between
cholestasis and hyperlipidemia. In one study, serum cholyl-
 
Abbreviations: HMG-CoA, 3-hydroxy-3-methylglutaryl coenzyme A;
ACAT, acyl coenzyme A:cholesterol acyltransferase; CEH cholesterol
ester hydrolase; DGAT, acyl coenzyme A:diacylglycerol acyltransferase;
LRP, low density lipoprotein receptor-related protein; LDL, low density
lipoproteins; VLDL, very low density lipoproteins; HDL, high density
lipoproteins; apo, apolipoprotein; MVA, mevalonate; FA, fatty acid.
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glycine levels doubled during pregnancy in all individuals
studied (22) suggesting that some degree of cholestasis is
normal in all pregnancies. Although the incidence of clin-
ically apparent cholestasis is less than 0.1–2% in most
countries, native American/Hispanic and Asian popula-
tions are at higher risk with a 10–20% incidence in some
subgroups (21–23).
Thus, in humans, pregnancy induces changes in choles-
terol metabolism that result in phenotypes associated with
the development of pathologies such as atherosclerosis and
cholesterol gallstone disease in the general population.
However, the origins of these changes remain obscure.
The liver plays a central role in the maintenance of
whole body cholesterol homeostasis by integrating regula-
tion of a group of hepatic enzymes, receptors, and other
proteins important for cholesterol, lipoprotein, and bil-
iary metabolism. The interactions and regulation of these
pathways to maintain cholesterol homeostasis during
pregnancy and lactation have not been studied systemati-
cally or in an integrated fashion. We hypothesized that he-
patic regulatory elements and their integration for main-
tainence of cholesterol homeostasis undergo major
changes during pregnancy and lactation to ensure that
cholesterol homeostasis is maintained optimally for both
the mother and the developing offspring and further, that
these changes are related to the etiology(ies) of hyperlipi-
demia and cholestasis of pregnancy.
The rat was chosen as a model for these studies be-
cause, like the human but unlike a number of other spe-
cies (24, 25), the rat develops hyperlipidemia during preg-
nancy (26–28) and, like humans, the rat also develops
cholestasis (29) as does the hamster (30). Thus, the rat is
a suitable model for studying the origins of changes in
both lipoprotein and biliary metabolism that are observed
during pregnancy and lactation in humans.
To gain further and more detailed insight into the regu-
lation of cholesterol, lipoprotein, and biliary metabolism
during pregnancy and lactation, the hepatic expression of
a number of enzymes, receptors, and proteins important
in hepatic cholesterol metabolism was investigated. A
scheme showing key elements involved in the regulation
of hepatic cholesterol, lipoprotein and biliary metabolism
is shown in 
 
Fig. 1
 
.
METHODS
 
Animals
 
Adult female (264–305 g) and timed pregnant (250–395 g)
Sprague-Dawley rats (Bantin and Kingman, Newark, CA, or
Simonsen, Gilroy, CA) were housed under reverse illumination
(lights on 3 
 
pm
 
; lights off 3 
 
am
 
) for at least 1 week prior to use.
They were allowed free access to food (Purina Rat Chow) and wa-
ter at all times. Animals were anesthetized with isoflurane, blood
was drawn into tubes containing gentamycin, 1 mg/ml, and
EDTA for lipoprotein profiles and/or into separate tubes for se-
rum, and the livers were removed. In pregnant animals the fe-
tuses were removed prior to removal of blood samples followed
by removal of the liver. All liver and blood samples were collected
at or about 9:00 
 
am
 
 (D6), except for two immediate post-delivery
samples (2 h) which were collected at 3:40 
 
pm
 
 and 6:15 
 
pm
 
. All
lactating dams had 9–14 suckling pups. Suckling pups were re-
moved from lactating dams at 21 days of age. All protocols were
approved by the Animal Studies Subcommittee at the VA Medical
Center, San Francisco.
 
Preparation of liver fractions
 
Homogenates, microsomal membranes, and cytosolic fractions
were prepared as previously described (31). A sinusoidal plasma
membrane-enriched fraction also was prepared as previously de-
scribed (32). All preparations were from freshly isolated livers.
 
Plasma and serum cholesterol and
triglyceride concentrations
 
Plasma and serum cholesterol and triglyceride concentrations
were determined as described previously (32).
 
Plasma lipoprotein profiles
 
Rat plasma collected as above was adjusted to density 1.21 g/
ml by the addition of solid NaBr and then subjected to ultracen-
Fig. 1. Scheme for hepatic cholesterol, lipoprotein, and biliary metabolism.
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trifugation at 40,000 rpm in a Beckman 40.3 rotor, for 24 h at
4
 
8
 
C. The d 
 
,
 
 1.21 g/ml fraction (top 1 ml) containing the lipo-
proteins was isolated by aspiration. The size distribution of VLDL
and LDL was determined on 2–16% non-denaturing polyacryl-
amide gradient gels, and of HDL, on 4–30% gels according to
the method of Nichols, Krauss, and Musliner (33).
 
Serum apolipoprotein profiles
 
Rat serum was fractionated by SDS gel electrophoresis and im-
munoblotted for apolipoproteins (apo) A-I, E, A-IV, C-III, and for
albumin using specific antisera provided by Dr. Karl Weisgraber
of the Gladstone Foundation, UCSF, and for apoB-100 and apoB-
48 using a specific antiserum provided by Dr. Robert Hamilton of
the Department of Anatomy, UCSF followed by densitometry. All
were assayed in the linear ranges of detection as determined in
preliminary experiments. The values are expressed in units de-
fined relative to a standard pooled rat plasma set as 100, an ali-
quot of which was run simultaneously on each gel.
 
Enzyme assays
 
Enzyme activities were measured in freshly prepared mi-
crosomes or cytosol. The activities of 3-hydroxy-3-methylglutaryl
coenzyme A (HMG-CoA) reductase (31), acyl coenzyme A:cho-
lesterol acyltransferase (ACAT) (34), the cholesterol ester hydro-
lases (CEH) (34), cholesterol-7
 
a
 
-hydroxylase (34), and acyl coen-
zyme A:diacylglycerol acyltransferase (DGAT) (35) were assayed
by radiochemical assays as previously described.
 
Hepatic receptor concentrations
 
Low density lipoprotein (LDL) receptor protein content was
estimated in membrane fractions enriched in sinusoidal plasma
membranes by SDS gel electrophoresis under reducing condi-
tions followed by transfer and immunoblotting as described
previously (32) using an LDL receptor-specific antiserum pro-
vided by Dr. Janet Boyles of the Gladstone Foundation, UCSF.
LDL receptor-related protein (LRP; 
 
a
 
2
 
-macroglobulin recep-
tor) content was estimated by 
 
45
 
Ca
 
11
 
 blotting based on the
method of Maruyama, Mikawa, and Ebashi (36) as described
previously (34). Scavenger recepter, Class B (SR-B1) content
was estimated by immunoblotting as described above using
whole liver homogenates prepared as described above and an
SR-B1 specific antiserum provided by Dr. Monty Krieger, De-
partment of Biology, MIT.
 
Hepatic mdr2 concentrations
 
mdr2 protein was estimated by immunoblotting as de-
scribed above using whole liver homogenates prepared as
described above and an mdr2-specific antiserum provided by
Dr. Irwin Arias, Departments of Physiology and Medicine,
Tufts University.
 
Other assays
 
Protein was estimated by the biuret method (37) using bovine
serum albumin as reference standard.
 
RESULTS
 
Serum cholesterol and triglyceride concentrations
 
As reported previously by others (26–28), pregnant rats
at term were hypercholesterolemic (
 
Fig. 2A
 
). This condi-
tion lasted throughout the lactation period. In contrast,
triglyceride concentrations were in the normal range in
near term rats. This may reflect the time of day at which
they were killed (D6); other studies used basal (L6) rats.
Triglycerides decreased to about one-third to one-half of
control, 
 
P
 
 
 
,
 
 0.001, after first suckling and remained low
throughout lactation (Fig. 2B). The day after weaning of
the pups, cholesterol concentrations were variably ele-
vated and remained significantly elevated thereafter until
21 days post weaning (42 days postpartum) when they
were similar to controls (Fig. 2A). Plasma triglyceride con-
centrations were elevated 4.4-fold after weaning of the
pups, (
 
P
 
 
 
,
 
 0.002, compared with controls); however, by 7
days post weaning, in contrast to cholesterol, triglyceride
levels were similar to controls and remained at this level
thereafter (Fig. 2B).
 
Plasma lipoprotein particle distribution
 
The distribution of VLDL, LDL, and HDL from lactat-
ing and control rats was determined by non-denaturing
polyacrylamide gel electrophoresis. Non-denaturing gra-
dient gel (2–16%) analyses, which profile VLDL and LDL,
showed that plasma from control rats possessed a small
Fig. 2. Plasma cholesterol and triglyceride concentrations during pregnancy, lactation, and post-lactation. The number of animals in each
group were: at day 21, 5; 10.08, 3, 10.75, 4, 13, 5; day 16, 2; day 112, 5; day 117, 2; day 118, 3; day 119, 7; day 122, 5; day 128, 4, day
142, 3; controls, 18 adult females. Pups were delivered at day 0. Negative days refer to days of pregnancy prior to birth. Pups were weaned at
day 21. Panel A, cholesterol; panel B, triglycerides.
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quantity of VLDL and LDL-size material (
 
Fig. 3A
 
). Con-
trol rat VLDL were of relatively small size with a mean par-
ticle diameter of 36–37 nm. The entire lactation period
was unique in that there was no evidence of VLDL parti-
cles (Fig. 3A). The control LDL were small in diameter
(23 nm). However, by the mid and late lactation period
(days 12–19, Fig. 3A) there was a clear shift to larger-sized
LDL particles (25–26 nm). Upon cessation of lactation
the VLDL–LDL pattern underwent major changes (Fig.
3B). The 1-day post-lactation stage was distinguished by
the absence of LDL particles and the presence of a sub-
stantial quantity of very large lipoproteins which re-
mained at the top of the gel (Fig. 3B). These particles
probably represent chylomicrons and/or large VLDL
and/or remnants in agreement with the high plasma tri-
glycerides observed at this time point. Seven days after ces-
sation of lactation, no VLDL were found although large
LDL (24.1 nm) again were seen (Fig. 3B). By 21 days post-
lactation, the VLDL–LDL profile was comparable to that
of controls (compare Fig. 3B with Fig. 3A).
HDL from control rats, as assessed by 4–30% non-dena-
turing gradient gel electrophoresis, consisted of a symmet-
rical peak with particles of large diameter (12 nm, Fig.
3A). During lactation, rather than becoming larger, the
particles were skewed towards smaller size. At 3 days, an
asymmetrical peak at 10.5 nm with a shoulder at 11.2 nm was
evident (Fig. 3A). With increasing time of lactation the HDL
particles became even smaller (9.7 nm at 19 days, Fig. 3A).
After the pups were weaned, the HDL pattern began to re-
vert to larger-sized particles and the pattern was normalized
by 21 days post-lactation (compare Fig. 3B with Fig. 3A).
 
Serum apolipoproteins
 
Relative to control, little statistically significant change
in apoB-100, which is mostly of liver origin, was observed
across the entire spectrum of pregnancy, lactation, and
post-lactation stages examined except for day 12 of lacta-
tion when it was increased about 2-fold, 
 
P
 
 
 
,
 
 0.05 (
 
Fig.
4A
 
). This corresponds to a time when the pups may begin
to ingest solid food as well as milk. ApoB-48, which is of
both liver and intestinal origin in the rat, was more vari-
able; in the late stages of pregnancy, levels were about 30–
40% higher than those in control (Fig. 4A). After first
suckling, apoB-48 was at control levels and remained simi-
lar to this until day 6 when levels had begun to increase.
By days 12 and 17 of lactation, apoB-48 had increased sig-
nificantly to about 2.5- to 3-fold greater than controls re-
spectively, 
 
P
 
 
 
,
 
 0.01. At this time point, serum apoB-48
may be enriched with that from the intestine because the
intestine has hypertrophied 2-fold by the midsuckling pe-
riod (38–40) potentially leading to increased secretion of
lipoproteins. The lack of VLDL-size particles and pres-
ence of large LDL-size particles at this time period suggest
that most of the apoB-48 may be in small remnants. Just
prior to weaning of the pups, apoB-48 levels decreased
about 50%, but nevertheless, they remained significantly
above control values, 
 
P
 
 
 
,
 
 0.01. Immediately after wean-
ing, apoB-48 increased to levels about 3-fold higher than
control, 
 
P
 
 
 
,
 
 0.005. This reflects the presence of the very
large lipoproteins found at this time period (see above)
which likely reflects an overshoot phenomenon due to
coupling of normal or enhanced intestinal chylomicron
production with a decrease in mammary gland produc-
tion of remnants. By 7 days post-lactation, apoB-48 levels
were similar to those in controls.
ApoE was decreased to 10–30% of the levels present in
controls in late pregnancy, at birth, throughout lactation,
and immediately after weaning (Fig. 4B; 
 
P
 
 
 
,
 
 0.05 at all
time points). Because most of the plasma apoE is thought
to be of liver origin, this suggests that liver production has
been down-regulated, perhaps to ensure longer residence
of lipoproteins in the circulation in order to fulfill placen-
tal and mammary gland requirements for lipids in late
pregnancy and for mammary gland milk production dur-
ing lactation. Alternatively, apoE levels are low because it
was removed very rapidly from the circulation, in particu-
lar, by the liver in late pregnancy and by other organs dur-
ing lactation. However, by 7 days after cessation of lactation,
levels of apoE had begun to increase and by 21 days post-
lactation, they were statistically similar to those of controls.
ApoA-IV also was markedly decreased during late preg-
nancy, about 15% of control levels, 
 
P
 
 
 
,
 
 0.001 (Fig. 4C).
However, after birth, levels increased to about 50% of con-
trol (
 
P
 
 
 
,
 
 0.02) and this level was maintained throughout the
early stages of lactation. By day 12 of lactation, apoA-IV had
increased to levels similar to control and remained at this
level until the pups were weaned when it dropped signifi-
cantly to levels about half those of control, 
 
P
 
 
 
,
 
 0.02. By 21
days post-lactation, apoA-IV had returned to control levels.
ApoA-I also was decreased in late pregnancy, to about
40% of control values, 
 
P
 
 
 
,
 
 0.01 (Fig. 4D). Levels dropped
Fig. 3. Lipoprotein size distribution patterns in plasma from lac-
tating and postlactating rats determined by non-denaturing gradi-
ent gel electrophoresis. Gels were stained with Coomassie R250 and
scanned for profiles. In all cases 2–16% gels provide profiles for
VLDL and LDL while 4–30% gels provide profiles for HDL. Panel
A: 3 days lactation; 12 days lactation; 19 days lactation; control.
Panel B: 1 day after removal of pups; 7 days after cessation of lacta-
tion; and 21 days after cessation of lactation. Numbers over the
peaks correspond to particle diameters in nm. Representative pro-
files are shown.
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further at birth but increased again to 50% of control by
day 3 of lactation, 
 
P
 
 
 
,
 
 0.02. At day 12 of lactation, values
were highly variable and not statistically significantly dif-
ferent from control. Thereafter, apoA-1 levels were main-
tained at about 50% of control, 
 
P
 
 
 
,
 
 0.02, until 21 days
post-lactation when they had returned to control levels.
ApoC-III levels also were significantly decreased during
the early to mid-lactating period (Fig. 4E), about 10–25%
of control values, 
 
P
 
 
 
,
 
 0.01, which may be coordinated
with the low apoE levels. Late pregnancy and post-lacta-
tion apoC-III values tended to be in the control range.
Taken together, the changes in apolipoproteins E, A-IV,
A-I, and C-III probably contribute to the changes in HDL
species described above.
 
Hepatic enzymes important in cholesterol, lipoprotein, 
and biliary metabolism
 
HMG-CoA reductase.
 
This is a rate-limiting enzyme for
mevalonate and cholesterol synthesis. Its activity was sup-
pressed about 60% (
 
P
 
 
 
,
 
 0.01) in pregnant animals rela-
tive to control (
 
Fig. 5A
 
). This reflects data on cholesterol
synthesis (41, 42) and HMG-CoA reductase (43) reported
by others and underlines the fact that the fetus makes
most of its own cholesterol rather than deriving it from
Fig. 4. Plasma apolipoprotein patterns for pregnant,
lactating, and post-lactating rats. The plasmas described
in Fig. 2 were used for analysis of the apolipoproteins as
described in Methods. Results are mean 6 SE. Panel A,
apoB (d, apoB-100; s, apoB-48); panel B, apoE; panel
C, apoA-IV; panel D, apoA-I; panel E, apoC-III.
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maternal lipoproteins (42, 44). Reductase activity in-
creased after delivery of the pups, reaching levels above
control by 3 days after birth (
 
P
 
 
 
,
 
 0.05) suggesting in-
creased need for de novo synthesis of cholesterol and/or
other mevalonate-derived products in this time period.
Reductase then began to decrease, falling to about 50%
below control level (
 
P
 
 
 
,
 
 0.02) by mid-lactation in agree-
ment with others (45). It did not return to control values
until 21 days post-lactation, suggesting a decreased re-
quirement for de novo synthesized sterols in the late lacta-
tion and post lactation periods.
 
Cholesterol-7
 
a
 
-hydroxylase. Biliary metabolism in rats is
known to be altered in pregnancy and lactation (29, 46–
48). Cholesterol-7a-hydroxylase is a rate-limiting enzyme
for cholesterol catabolism and bile acid synthesis. Its activ-
ity was very low in late pregnancy, about 10% of control,
P , 0.002, (Fig. 5B) consistent with reports of cholestasis
at this time point (29). 7a-Hydroxylase activity increased
about 4-fold just before the animals gave birth although it
remained below control values. 7a-Hydroxylase activity
fell again after birth, but increased after first suckling,
reaching control values by day 3. This suggests that the
cholestasis of pregnancy had been reversed significantly.
However, by day 6 of lactation, levels of 7a-hydroxylase ac-
tivity had decreased significantly (P , 0.05), and by day
12, had dropped to 10% of control, P , 0.001. Activity
then increased modestly to reach about 30% of control by
day 19 of lactation, P , 0.002, and remained low until re-
turning to values similar to control by 21 days post-lacta-
tion. The data taken together suggest that some level of
intrahepatic cholestasis may have been present during
much of the lactation period or alternatively, an increased
enterohepatic circulation is present.
ACAT. This activity is rate-limiting for intracellular cho-
lesterol esterification. ACAT levels had been determined
previously in near-term pregnant rats assayed using the
endogenous cholesterol pool as substrate (43). In the
present work, ACAT activity in pregnant rats was 32–64%
lower than controls, P , 0.02, (Fig. 6A) when assayed using
endogenous cholesterol as substrate. ACAT was somewhat
higher in early lactation, reaching about 2-fold (P , 0.05)
on day 6, but then fell below control, about 50% (P ,
0.02) by day 12 and remained at this level until 21 days
post-lactation when it had returned to control levels.
These changes likely reflect, at least in part, the availabil-
ity of free cholesterol substrate from various metabolic
pools in the liver. In contrast, when ACAT activity was
assayed with exogenous cholesterol, which measures the
activity under apparent Vmax conditions, and thus, approx-
imates the amount of active ACAT enzyme present, activi-
ties were lower than control throughout pregnancy and
lactation at most time points assayed (Fig. 6A). In near-
term pregnant animals, activity was 40% of control (P ,
0.001), but it increased after delivery, reaching values in
the control range by day 6 of lactation. By day 12 of lacta-
tion, activity had declined and by day 17, was 37% of con-
trol (P , 0.02). By day 19, activity again increased to
58% (P , 0.02) of control. After weaning of the pups, ac-
tivity dropped to 27% of control (P , 0.001); however, as
the length of post-lactation time increased, activity be-
gan to return to control values and by 21 days post-lacta-
tion, it was similar to control values. These data taken to-
gether suggest that the amount of active ACAT present
may be regulated by factors other than substrate availabil-
ity per se.
DGAT. This activity is the rate-limiting enzyme for tri-
glyceride synthesis. It was about 2-fold higher than con-
trol at day 19 of pregnancy (P , 0.05) (Fig. 6B) suggest-
ing an increased requirement for synthesis and secretion
of lipoprotein triglycerides, likely for use by the placenta
and mammary glands. VLDL secretion is reported to be
increased at this time point (46). Thereafter, values were
below control (P , 0.05) at all time points until day 22, 1
day after weaning. This suggests that the liver may not se-
Fig. 5. Hepatic HMG-CoA reductase and cholesterol 7a-hydroxylase activities during pregnancy, lactation, and post-lactation. The num-
bers of animals in each group were for reductase: at day 24, 5; day 21, 6; day 10.08, 3; day 10.75, 6; day 13, 5; day 16, 6; day 112, 5; day
117, 2; day 119, 6; day 122, 4; day 128, 4; day 142, 3; controls were adult females, n 5 3. For 7a-hydroxylase, they were: at day 24, 4; day
21, 4; day 10.08, 3; 10.75; day 13, 4; day 16, 4; day 112, 4; day 117, 2; day 119, 5; day 122, 5; day 128, 3; day 142, 3; controls were adult
females, n 5 9. Results are mean 6 SE. Panel A, reductase, panel B, 7a-hydroxylase.
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crete large amounts of triglyceride-rich lipoproteins af-
ter parturition, and supports the notion that much of
the apoB-48 in plasma is of intestinal origin during the
lactation period (see above). At day 22, DGAT was about
3 times higher than previously (P , 0.05) and almost
twice that of control. This suggests a response by the
liver to an influx of free fatty acids and of triglyceride-
enriched lipoproteins due to cessation of lactation, be-
ginning of involution of the mammary gland, and down-
regulation of mammary gland lipoprotein lipase. By 21
days post-lactation, values for DGAT were indistinguish-
able from control.
Neutral cholesterol ester hydrolase. These activities are both
cytosolic and membrane-associated. They are responsible
for cellular hydrolysis of cholesteryl esters. These en-
zymes may play roles in regulating the amount of free
cholesterol in the cell and in facilitating selective uptake
of cholesteryl esters from lipoproteins. The specific activ-
ity of neutral CEH was higher in hepatic microsomes
compared with hepatic cytosol at all time points studied
with the exception of livers from 19-day pregnant animals
in which the microsomal specific activity was similar to
that in cytosol (Fig. 7A). CEH in both compartments was
decreased to 60% of the control value (P , 0.001) in
these animals suggesting decreased intracellular free cho-
lesterol needs from these sources. The microsomal activ-
ity increased through the remainder of pregnancy and af-
ter delivery of the pups, reaching values 40% higher than
control by day 3 of lactation (P , 0.05). It then decreased
to levels similar to control by day 6. From the mid- to late-
lactation stages, activity again increased, reaching 140%
(P , 0.005) and 130% (P , 0.02) of control by days 17
and 19 of lactation, respectively, suggesting increased
needs for free cholesterol. Activity returned to control
levels after weaning of the pups, but it was at a higher
level at 21 days after cessation of lactation (P , 0.05).
The pattern of neutral CEH activity in cytosol was differ-
ent from that in microsomes (Fig. 7A). Activity in near
term dams was 72% of that in controls, P , 0.02. After
birth, levels similar to control were maintained until day
12. The activity then dropped to about 70% of control,
P , 0.02. After weaning of the pups, activity had declined
further to 47% of control (P , 0.05), the lowest level of
all the time points examined. This was in marked contrast
to the microsomal activity which had increased. CEH cy-
tosolic activity was similar to control values at 21 days
post-lactation. The data taken together suggest that these
two enzyme activities are different proteins subject to dif-
ferent regulatory mechanisms.
Acidic cholesterol ester hydrolases. These activities prima-
rily represent lysosomal and endosomal activities and
likely play a key role in making cholesterol and fatty acids
available from lipoproteins that have been internalized by
receptor-mediated endocytosis. The specific activity of
acidic CEH was greater in microsomes than in the corre-
sponding cytosolic fractions at all time points examined
(Fig. 7B). Microsomal acidic CEH activity was similar to
control from just after birth through late suckling. At
weaning, it dropped to 65% that of control, P , 0.05.
However, by 21 days post-lactation, activity was 1.7-fold
greater than control, P , 0.04, suggesting that the en-
docytic pathway may be more active at this time. Cytosolic
acidic CEH activity in near term and early lactating dams
was similar to controls (Fig. 7B). However, at 6 days of lac-
tation it was about half that of control, P , 0.02, and re-
mained at this level until 1 week post-lactation. By 21 days
post-lactation, activity was similar to control values.
Hepatic cell surface receptors and proteins important in 
cholesterol, lipoprotein, and biliary metabolism
LDL receptors. These receptors recognize both apoB-
100 and apoE. The liver LDL receptors are responsible for
much of the clearance of LDL and apoE-containing lipo-
proteins from the plasma (for review, cf. ref. 49). In late
pregnant animals LDL receptor protein level was similar
to that of controls (Fig. 8A); it increased after delivery,
Fig. 6. Hepatic ACAT and DGAT activities during pregnancy, lactation, and post-lactation. Experimental details are the same as for reduc-
tase in Fig. 5. Results are mean 6 SE. Panel A, ACAT, d, activity determined in the absence of exogenous cholesterol; s, activity determined
in the presence of exogenous cholesterol; panel B, DGAT.
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P , 0.02, and reached a value 2-fold higher (P , 0.001)
by 18 h post-partum (after first lactation). Over the next 6
days of the lactating period, levels fell to control levels.
However, by day 12 (mid-lactation period) LDL receptors
had increased to about 150% of control (P , 0.004) and
remained at this level through 21 days post-lactation, sug-
gesting a need for increased lipoprotein clearance via the
endocytic pathway in this time period.
LRP or a2-macroglobulin receptors. This receptor recog-
nizes apoE and other ligands (50, 51). Thus, its levels re-
flect requirements both for lipid metabolism and for
plasma protein clearance. The LRP level was similar to
control in 19-day pregnant dams; however, just prior to de-
livery, LRP increased about 2-fold (P , 0.001) (Fig. 8B). It
then fell to levels somewhat higher than control at post
parturition followed by a 1.6-fold (P , 0.02) increase at
day 3 before dropping to about 50% (P , 0.02) of control
by day 6. LRP then rose to reach a value similar to control
by day 12 followed by a further increase (about 1.6-fold,
P , 0.05) at day 18. Just prior to weaning, LRP levels fell
30% to near control. After weaning of the pups, LRP in-
creased 1.5- to 1.7-fold higher than control, P , 0.02, and
remained elevated at 7 and 21 days post-lactation, suggest-
ing increased need for clearance of this receptor’s ligands
from the circulation in this time period.
The patterns of both LDL receptors and LRP likely re-
flect not only requirements for nurture of the fetuses and
pups, but also tissue remodeling processes necessary for
pregnancy, parturition, lactation, and return to a control
state. These receptors also do not regulate in parallel at all
time points, suggesting differential control mechanisms.
SR-B1. This receptor has been proposed to be involved
in selective uptake (52) of cholesteryl esters both from
HDL and LDL (53) and in regulation of biliary choles-
terol levels (54). Its levels were increased in late preg-
nancy and at birth, about 2-fold (P , 0.05) (Fig. 9A) sug-
Fig. 7. Neutral CEH and acidic CEH activities in hepatic cytosol and microsomes during pregnancy, lactation, and post-lactation. Experi-
mental details are the same as for reductase in Fig. 5. Results are mean 6 SE. s, cytosol; d, microsomes. Panel A, neutral CEH; panel B,
acidic CEH.
Fig. 8. Hepatic LDL receptor and LRP (a2-macroglobulin receptor) protein concentrations during pregnancy, lactation, and post-lacta-
tion. A sinusoidal membrane-enriched fraction of rat liver was prepared and assayed as described in Methods. Experimental details are the
same as for reductase in Fig. 5 except that the control represents the results from 29 individual adult females for LDL receptors and the re-
sults from 25 adult females for LRP. Results are mean 6 SE. Panel A, LDL receptor; panel B, LRP.
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gesting that selective uptake was a significant source of
exogenous cholesterol in this time period. By day 3 postpar-
tum, values were similar to control. They remained in this
range until day 19 of lactation when they had dropped
about 75% (P , 0.01). The day after weaning of the pups,
SR-B1 levels had risen to the control range and remained
within the control range thereafter. This pattern is quite
different from that for the LDL receptor at most time
points and suggests that cholesterol derived from selective
uptake may be compartmentally and metabolically differ-
ent from that derived from receptor-mediated endocyto-
sis. The data also suggest different regulatory mechanisms
are operational for these receptors.
mdr2. This protein is a member of the multidrug resis-
tant gene family. It is involved in lipid secretion into bile
(55). Mice deficient in mdr2 develop intrahepatic choles-
tasis and impaired biliary excretion of both phospholipids
and cholesterol (55). mdr2 levels were in the control
range during pregnancy, but they increased to about 50%
above control (P , 0.05) after birth and first suckling of
the pups (Fig. 9B) suggesting increased biliary secretion
of phospholipid and cholesterol could occur at this time
point. mdr2 remained elevated until day 19 when it re-
turned to control values, suggesting increased demand for
biliary lipid secretion throughout the lactation period. At
day 22, after weaning of the pups, mdr2 was significantly
elevated relative to day 19 (P , 0.05) suggesting an even
greater requirement for increased biliary lipid secretion.
mdr2 levels decreased thereafter to within the control
range. The data suggest that these changes reflect liver
lipid flux as well as biliary phospholipid and cholesterol
secretion requirements per se.
DISCUSSION
Based on the marked changes in plasma and biliary me-
tabolism reported during pregnancy and/or lactation in
both humans and rats (this work and references 1–9, 11–
13, 16–23, 26–30), it is clear that major changes in hepatic
lipid metabolism must occur in order to maintain choles-
terol homeostasis for both the mother and offspring si-
multaneously. Despite these observations, few of the puta-
tive regulatory elements involved had been studied
previously and then usually only at limited time points,
making it difficult to understand how the various ele-
ments of cholesterol metabolism are integrated in these
metabolic states. Table 1 summarizes the findings at the dif-
ferent time points studied. Of additional interest is the fact
that liver total, free, and esterified cholesterol levels are re-
ported to be unchanged during pregnancy and lactation
(42, 43, 56) as are liver triglycerides (56). This suggests
that a gross cellular balance in these lipids is maintained.
Effects of pregnancy. Although LRP (a2-macroglobulin
receptor) and LDL receptors, both of which utilize the
endocytic pathway to deliver their ligands, were in the
control range in late pregnancy, they increased at partu-
rition. SR-B1 was high both in late pregnancy and at par-
turition. In contrast, HMG-CoA reductase was low. These
data suggest that the liver was preferentially utilizing lipo-
protein-derived cholesterol, rather than de novo synthe-
sized cholesterol as a substrate for VLDL secretion, known
to be higher in late pregnancy (46). This increased VLDL
secretion would explain the increase in DGAT activity at
this time point and suggests diversion of diacylglycerols
from biliary phospholipid synthesis to triglyceride synthe-
sis. Consistent with the high DGAT activity, ACAT activity,
which competes with DGAT for fatty acyl CoA, was low
during pregnancy.
mdr2 was lower in late pregnancy than after birth sug-
gesting that the relative decrease in mdr2 resulted in
decreased biliary phospholipid secretion capacity and
cholestasis as reflected also by the low cholesterol 7a-
hydroxylase activity. This decreased biliary phospholipid
secretion also would make more phospholipid available
for VLDL assembly and secretion.
Taken together, the data suggest that in late pregnancy,
liver lipid metabolism may be directed towards VLDL se-
Fig. 9. Hepatic SR-B1 and mdr2 concentrations during pregnancy, lactation, and post-lactation. Rat liver homogenates were prepared and
analyzed as described in Methods. Each point is the mean 6 SE for at least 3 animals. Panel A, SR-BI; panel B, mdr2.
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cretion at the expense of biliary secretion. This would sup-
ply lipids, especially triglycerides, to the placenta for fetal
energy requirements and to the mammary gland for milk
lipids in anticipation of the onset of suckling (57–60).
Effects of birth and first suckling. Both LDL receptors and
SR-BI increased after first lactation, suggesting an in-
creased hepatic requirement for cholesterol, likely for bile
acid synthesis and secretion and biliary secretion of cho-
lesterol as suggested by the abrupt rise at this time in
cholesterol 7a-hydroxylase activity relative to its level dur-
ing pregnancy and the increase in mdr2. This latter
change also could result in reversal of any pregnancy-
induced hepatic cholestasis. ACAT also increased after
birth, concomitant with the drop in DGAT and the in-
crease in LDL receptors, indicating that significant num-
bers of apoE- and/or apoB-containing plasma lipopro-
teins are being cleared from the circulation and that this
lipoprotein cholesterol enters the ACAT substrate pool. In
addition to the increase in lipoprotein receptors, HMG-
CoA reductase also increased, likely in part to provide de
novo synthesized cholesterol and bile acids to the biliary
pool, cholesterol to membranes for liver hypertrophy
known to occur during the lactation period (38–40), and for
lipoprotein secretion to provide cholesterol and triglycer-
ides for milk production (57–59). The increase in reductase
also may have been to satisfy increased needs for nonsterol
mevalonate products necessary for liver hypertrophy.
Taken together, the changes at this time point suggest
that requirements both for de novo synthesized meva-
lonate and cholesterol and for exogenous (lipoprotein)
cholesterol via the LDL receptor-mediated endocytotic
pathway had increased substantially and were important
for maintenance of both hepatic and whole body choles-
terol homeostasis.
Effects in the lactation period. Little has been reported
on lipoprotein profiles during lactation in any species. In
the present work plasma triglyceride levels of lactating rats
were low, while plasma cholesterol levels were elevated. As
a reflection of this, plasma VLDL particles were absent
during lactation. Nevertheless, apoB levels were generally
increased as a consequence of the increase in LDL-size
particles, whereas apos E, A-I, A-IV, and C-III were gener-
ally decreased, reflecting the changes in HDL profile. The
data, taken together, suggest that triglyceride-rich parti-
cles are rapidly cleared from the circulation during the
lactating phase, likely by conversion to IDL/LDL-size par-
ticles through the action of mammary gland lipoprotein
lipase to supply lipids for milk production (57, 58). Milk
triglycerides and cholesterol are known to be derived
from lipoproteins (59) as well as from de novo synthesis in
the mammary gland (59, 60).
In early lactation, HMG-CoA reductase, ACAT, neutral
CEH, LDL receptors, LRP, and SR-B1 were all elevated,
suggesting that requirements for increased hepatic cho-
lesterol availability are great in the initial period of lacta-
tion. These changes coincide with the known increased
concentration of cholesterol in rat’s milk in the early
stages of lactation (61, 62), and beginnings of evident hy-
pertrophy of the liver and proliferation of the intestine
(38–40), both of which require increased cholesterol
availability for membrane synthesis. Thus, the increases in
hepatic activities likely reflect increased requirements for
lipoprotein cholesterol to satisfy needs of the mammary
gland and probably also the intestine. Increased bile acid
synthesis and biliary secretion as shown by the increases in
7a-hydroxylase and mdr2 likely are to promote increased
lipid absorption from the intestine to maintain both the
mother and offspring optimally.
TABLE 1. Summary of changes in elements related to cholesterol and lipoprotein
metabolism during pregnancy and lactation
Late Preg Delivery 1st Suckling Early Lact. Mid Lact. Late Lact. Weaning 1wk Post 3 wks Post
Choles › › › › › › ›fi › fi
TG fi fi fl fl fl fl ››› fi fi
VLDL › fl fl fl › › fl fi
LDL › › › fl › fi
HDL small HDL ‹ fi HDL size increasing
ApoB-100 ›fi fi ›fi fi › fi fi fi fi
ApoB-48 › fi fi ›fi › ›› ››› fi fi
ApoE fl fl fl fl fl fl fl fl fi
ApoA-IV fl fl fl fl fl fi fi fl fl fi
ApoA-I fl fl fl fl flfi fl fl fl fi
ApoC-III flfi fl fl fl fl fl fl flfi ND
Reductase flfl fl fl ›fi fl fl fl fl fi
ACAT endo fl flfl fl › fl fl fl fl fi
ACAT exo fl fl fl flfi fl fl fl fl fi
DGAT ›› fl fl fl fl flfl ›› fl fi
NCEH m fl fl fi › ›fi › fl fi ›
NCEH cy fl fl flfi fi flfi flfi fl fl fi
LDLR fi › › fi › › › › ›
LRP fi › fi flfi › › › › ›
ACEH m flfi fl fi flfi fi fi fl fl ›
ACEH cy fl fi fi fl fl fl fl fl fi
7a-H flfl fl fl fi fl fl fl fl fi
SRB1 ›› › ›› ›fi ›fi fl fi fi ›fi
mdr2 fi › › › › fi › fi fi
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Changes in hepatic cholesterol metabolism are evident
again at day 6 of lactation. HMG-CoA reductase and ACAT
are still elevated; however, the other elements have de-
creased, including all of the lipoprotein receptors. This sug-
gests that decreased amounts of the plasma lipoproteins are
being cycled back to the liver, allowing sequestration of lipo-
protein lipid by the mammary gland to support growth of
the offspring via milk production and also by the intestine
to support its needs for increased growth and absorption.
Around the mid-lactation point (about day 12) hepatic
LRP and LDL receptors increased. This coincides with a
decrease in cholesterol content of the milk (61) suggest-
ing the liver has begun to increase clearance of plasma
lipoproteins to compensate for declining needs of the
mammary gland. The decreases in reductase and 7a-
hydroxylase also likely reflect this decreased need.
HDL metabolism also was altered in the mid-lactation
and post-lactation periods. A shift from large particles to
smaller ones was associated with preferential decrement
of a specific subpopulation of HDL because although a
major peak was present at 10.5 nm, the shoulder at 11.2
nm, still in evidence after 3 days of suckling, disappeared
as the lactation period proceeded. This was consonant
with the decreased concentrations of plasma apoE, apoA-
I, A-IV, and apoC-III found during lactation. Recently,
strong evidence has been published that HDL cholesterol
is preferentially secreted in bile (63) and other reports
suggest it can be a precursor for bile acids (64, 65). Fur-
ther, evidence of coordinate genetic control of HDL levels
and bile acid metabolism was published recently (66).
Thus, the changes in HDL species may reflect changes in
hepatic biliary metabolism during this period.
Effects at weaning and 3 weeks later. The next point of ma-
jor change was around the time of weaning. Just prior to
this both LRP and SR-B1 decreased dramatically, perhaps
in response to weaning-related regulatory processes. The
striking increase in dam’s plasma triglyceride concentra-
tions and apoB-48 immediately after weaning of the pups
mirrored the presence of very large lipoprotein particles
in the plasma, suggesting a rebound effect wherein mam-
mary gland lipoprotein lipase activity is essentially down-
regulated, but the intestine still produces large amounts
of triglyceride-rich lipoproteins. As the intestine is still al-
most 2-fold larger in mass at this time point (38–40) the
proportion of intestinally derived lipoproteins in the
plasma likely is high. The persistence of large triglyceride-
rich particles during early post-weaning continues to re-
flect this state and is further evidence that triglyceride
contained in these particles represented a significant
source of lipid for secretion into milk.
Liver DGAT also increased at weaning. This likely re-
flects, in part, increased availability of cellular free fatty ac-
ids due to decreased uptake of triglycerides by mammary
gland and consequently, return of increasing amounts of
both lipoprotein triglycerides and probably, free fatty ac-
ids, to the liver as the mammary gland begins to involute.
LDL receptors, LRP, and mdr2 also all increased after
weaning, suggesting a response to the tissue alterations
and remodeling which were beginning to occur, in partic-
ular, return of the mammary gland, liver, intestine, and
circulatory elements to a control state.
Most of the hepatic elements were at control levels by
21 days post-lactation. However, LDL receptors, LRP, and
acidic CEH remained markedly elevated at this time
point, suggesting that the liver endocytic pathway was up-
regulated specifically, perhaps to continue to deal with the
extensive physiological tissue remodeling that occurs after
weaning. The membrane-associated neutral CEH also was
up-regulated with variable increases in SR-B1, suggesting
they too were playing a role. The data also demonstrate
that the metabolic response time to normalize the differ-
ent hepatic and plasma elements involved is variable and
suggest that coordinate regulation of the different ele-
ments occurs by different mechanisms dependent on the
physiological state of the mother.
Taken together, the above data provide for the first time
an integrated picture of hepatic cholesterol and lipopro-
tein metabolism during pregnancy, lactation, and post-
lactation. Clearly, major compensatory changes in the reg-
ulatory elements of hepatic cholesterol metabolism occur
during these important physiological states. Further, the
data taken together provide a biochemical rationale at
the level of the liver both for the hyperlipidemia of preg-
nancy and for the cholestasis of pregnancy and for their
resolution. In addition, these results emphasize the com-
plexity of the degree and type of integration of regulation
of the various key elements involved in cholesterol metab-
olism observed under these conditions.
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